Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Interest Expenses (2017 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Interest Expenses for 11 consecutive years, with $155000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 162.71% to $155000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $309000.0, a 14.87% increase, with the full-year FY2025 number at $309000.0, up 14.87% from a year prior.
  • Interest Expenses was $155000.0 for Q4 2025 at Ekso Bionics Holdings, up from $18000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $155000.0 in Q4 2025 to a low of $18000.0 in Q3 2025.
  • A 5-year average of $57500.0 and a median of $60000.0 in 2023 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: surged 314.81% in 2023, then tumbled 77.22% in 2025.
  • Ekso Bionics Holdings' Interest Expenses stood at $36000.0 in 2021, then surged by 83.33% to $66000.0 in 2022, then changed by 0.0% to $66000.0 in 2023, then fell by 10.61% to $59000.0 in 2024, then surged by 162.71% to $155000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Interest Expenses are $155000.0 (Q4 2025), $18000.0 (Q3 2025), and $64000.0 (Q2 2025).